J.B. v. Commissioner of the Social Security Administration

District Court, D. South Dakota·Decided August 19, 2026·No. 4:25-cv-04247·Unknown

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF SOUTH DAKOTA SOUTHERN DIVISION

J.B., 4:25-CV-04247-RAL

Plaintiff,

vs. REPORT & RECOMMENDATION

COMMISSIONER OF THE SOCIAL SECURITY ADMINISTRATION;

Defendant.

INTRODUCTION Plaintiff, J.B., seeks judicial review of the Commissioner’s final decision denying his application for Social Security disability benefits under Title II of the Social Security Act. Plaintiff seeks an order from this court reversing the Commissioner’s final decision denying his disability benefits and remanding the matter to the Social Security Administration for further proceedings. See Docket Nos. 1, 14, & 18. The Commissioner seeks affirmance of the agency’s decision below. See Docket No. 17. This appeal of the Commissioner’s final decision denying benefits is properly before the court pursuant to 42 U.S.C. § 405(g). The district court has referred this matter to this magistrate judge for a recommended disposition pursuant to 28 U.S.C. § 636(b)(1)(B) and DSD LR 83.9. FACTS A. Procedural History Plaintiff was 39 years old on the date he alleged he became disabled.

Administrative Record (“AR”) 30. Plaintiff has a two-year college education. AR241. His past work experience includes being a janitor, a machinist, a correctional officer, and a delivery driver. AR241. Plaintiff applied for disability benefits on November 17, 2022, alleging a date of disability of January 1, 2022. AR17. Plaintiff was found by the ALJ to have the following severe impairments: osteoarthritis lumbar spine; gout; 5mm nonenhancing lesion in inferior fourth ventricle; binocular vision disorder with diplopia; neurocognitive disorder; anxiety; attention deficit hyperactive disorder

(ADHD); and depression. AR20. Plaintiff’s claim was denied initially on October 2, 2023, and denied again upon reconsideration on April 19, 2024. AR17. B. Medical Evidence 1. June 26, 2021, Emergency Department Visit On June 26, 2021, plaintiff presented to St. Michael’s Hospital in Tyndall, South Dakota, complaining of elevated blood pressure. AR345-46. On arrival, plaintiff’s blood pressure was 180/88, which is high.1 After plaintiff “was more relaxed” his blood pressure lowered to 138/81. Id. Doctors approved

of plaintiff discontinuing his Lexapro and recommended that he take his

1 A top number of 140 or higher places an individual in the stage 2 hypertension category. See Mayo Clinic, Blood Pressure Chart: What Your Reading Means (Dec. 24, 2025), https://www.mayoclinic.org/diseases- conditions/high-blood-pressure/in-depth/blood-pressure/art-20050982. Vistaril as prescribed for anxiety and that he follow up with his primary care provider. Id. 2. Yankton Medical Clinic Records

Plaintiff attended the Yankton Medical Clinic from May 17, 2021, to July 29, 2022. AR350-70. During that time, plaintiff was treated for snoring, sleep apnea, and excessive daytime sleepiness. AR369. Plaintiff was given a CPAP machine2 and reported afterwards that he slept better and felt better rested. AR362. 3. Behavioral Health Records Between April 21, 2022, and July 31, 2024, plaintiff received treatment from Lewis & Clark Behavioral Health in Yankton, South Dakota. AR371-441.

Plaintiff told providers that he had “been dealing with anxiety for 20 years and would like to get help.” AR378. Plaintiff noted that he had been taking Paxil for three years, but discontinued use due to side effects. Id. He also discontinued use of Fluoxetine. Id. Plaintiff revealed that he used marijuana two or three times per day to alleviate his symptoms, and that this had been effective. AR378, 397. He also reported that his 150mg of bupropion had been “amazing” and that “his mood and anxiety have been so much better and that his ability to focus and

concentrate is significantly improved as well.” AR398. His bupropion was later

2 CPAP stands for “continuous positive airway pressure.” A CPAP machine is a common treatment for sleep apnea that keeps an individual’s airways open while they sleep. See Cleveland Clinic, CPAP Machine (July 11, 2024), https://my.clevelandclinic.org/health/treatments/22043-cpap-machine. increased to 300mg daily, and he was prescribed 25mg hydroxyzine twice daily as needed. AR424, 433. He observed that the increased dose may have caused a dissociative episode at work. AR424.

Plaintiff told providers of the problems his anxiety presented him, including panic attacks, shakiness, trouble with concentration, repeating words or phrases on a loop, seizing up, sweating, chest tightening, shortness of breath, and trouble hearing. AR378. Providers diagnosed plaintiff with generalized anxiety disorder and ADHD. AR386. Plaintiff also reported difficulty remembering projects and appointments, avoiding activities that required a lot of thought or attention, fidgeting, being easily distracted, difficulty paying attention, and difficulty organizing tasks. AR378. After beginning a job at

Walmart, plaintiff reported that his anxiety increased somewhat. AR415. Plaintiff indicated that his depression was not severe, denying poor sleep, decreased interest levels, decreased energy, recent changes to appetite or weight, or suicidal ideation. AR397. He also denied any issues with paranoia, hallucinations, delusions, eating disorders, obsessions or compulsions, fears or phobias, mania, or symptoms of PTSD. Id. Plaintiff was diagnosed with a brain tumor in 2023. AR544. Plaintiff reported that he experienced some additional anxiety, but overall stated that he

tolerated his medications well and felt that his symptoms had been well controlled. AR671. At one session on July 10, 2023, plaintiff denied any symptoms of depression, including poor sleep or difficulty with concentration or focus. AR680. At another appointment on October 2, plaintiff reported that he was managing his anxiety well and denied having any significant anxiety attacks. AR689. At an appointment on June 13, 2024, plaintiff complained of an increase

in depression and anxiety. AR896. He said that he had low levels of motivation and energy and spent a lot of time focusing on future worries and past regrets. Id. While he said that his Wellbutrin had been beneficial, it did not provide relief for his anxiety symptoms. Id. Plaintiff met with providers again on July 31, 2024. AR905. He again complained of increased depression and anxiety. Id. He had previously been prescribed 30mg of duloxetine daily, and said that his overall mood had improved since starting the medication. Id. He reported that he is “almost back

to where he would like to be” and that he was finding enjoyment again in daily activities. Id. While he reported anxiety, he “denie[d] that it’s significant enough to cause any impairment in his day.” Id. 4. Horizon Healthcare Plaintiff received care from Horizon Healthcare in Yankton, South Dakota, from May 3, 2021, to March 12, 2024. AR463-535. Plaintiff originally began treatment at Horizon Healthcare because he wanted to have his knees evaluated due to weakness and pain in his joints. AR526. Plaintiff also wanted

to be seen for anxiety and depression and to see a pulmonologist regarding his sleep apnea. AR526-27. Plaintiff primarily received therapy from Horizon Healthcare over the course of two years. See, e.g., AR523. During those appointments, plaintiff discussed his anxiety and depression and coping skills for dealing with them. AR503. At one appointment, plaintiff recounted an episode in April 2022 where he became

Free access — add to your briefcase to read the full text and ask questions with AI

J.B. v. Commissioner of the Social Security Administration, (D.S.D. 2026).

J.B. v. Commissioner of the Social Security Administration (J.B. v. Commissioner of the Social Security Administration) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Brown v. Apfel
192 F.3d 492 (Fifth Circuit, 1999)
Richardson v. Perales
402 U.S. 389 (Supreme Court, 1971)
Heckler v. Campbell
461 U.S. 458 (Supreme Court, 1983)